Company intelligence
CS Life Science Invest
Your Partner for Strategic Growth and Value Creation in Deep Tech
About CS Life Science Invest
CS Life Science Invest is a strategic growth partner for life sciences and deep tech companies, specializing in scaling valuation, securing funding, and preparing organizations for M&A, IPO, or high-value exits. With 25+ years of executive and advisory experience, we help leadership teams move from early-stage complexity to structured, investment-ready clarity—aligned with public market and acquirer expectations. We work closely with CEOs, boards, and investors to: • Shape strategic narratives that command investor trust and market attention • Architect financial and corporate structures that withstand due diligence • Unlock capital, strategic partnerships, and exit opportunities through global networks Our expertise is built on execution—not theory: • Over $100M raised and managed in VC-backed companies • Participation in $1B+ M&A transactions across life sciences and deep tech • Strategic assessment of 1,000+ public and private companies globally • Board-level leadership in preparing companies for funding, scaling, and exits Our Services: ✔ Board & Executive Advisory — Leading growth from spin-out to IPO, M&A, or sustainable market leadership ✔ Fundraising & Strategic Partnering — Connecting to global venture, institutional, and corporate capital ✔ Deep Tech & Life Sciences Acceleration — Aligning teams, structure, and strategy to scale outcomes ✔ Exit Positioning — Structuring companies to attract strategic buyers and investors ✔ On- and Offline Visibility — Amplifying leadership positioning through media, investor engagement, and thought leadership (including the Beginner’s Mind Podcast) Our approach is designed for leaders who want more than survival. We help companies scale smart, position decisively, and exit successfully—with the structure, clarity, and leverage required to win. Explore insights and success stories on the Beginner’s Mind Podcast: https://beginnersmind.buzzsprout.com/
Verified activity
Signals from CS Life Science Invest
6 published signals
Capital & Finance
CS Life Science Invest published data showing that twelve years later, European taxes and valuations drive people away from US funds.
Reported by Christian Soschner
Customers & Market
CS Life Science Invest entered into a deal with Menarini to pay Gan & Lee 62 million euros upfront, plus up to 664 million in milestones and double-digit royalties, for bofanglutide, a GLP-1 dosed once every two weeks, with Phase 3 in China and Phase 2 in the US meeting their primary endpoints.
Reported by Christian Soschner
Partnerships
CS Life Science Invest announced that Salesforce has partnered with Anthropic on Claudeforce.
Reported by Christian Soschner
Partnerships
CS Life Science Invest announced that Klaviyo has partnered with Anthropic on Composer builds campaigns.
Reported by Christian Soschner
Partnerships
CS Life Science Invest announced that Docusign has partnered with Anthropic on Iris reviews contracts.
Reported by Christian Soschner
Partnerships
CS Life Science Invest announced that Atlassian has partnered with Anthropic on Rovo routes and resolves requests.
Reported by Christian Soschner